74 related articles for article (PubMed ID: 2390764)
1. Effect of alkyl-lysophospholipid analogs on the morphology of a murine lymphoma cell line.
Vagnetti D; Mancini A; Santarella B; Binaglia L
J Submicrosc Cytol Pathol; 1990 Jul; 22(3):415-24. PubMed ID: 2390764
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of 1-O-alkyl-2-O-methyl-glycerophospholipids with potential antitumor activity.
Alunni-Bistocchi G; Orvietani PL; Ricci A; Binaglia L; Orlando M; Orlando P
Farmaco; 1990 May; 45(5):499-509. PubMed ID: 2222722
[TBL] [Abstract][Full Text] [Related]
3. Tumor cell kinetics following long-term treatment with antineoplastic ether phospholipids.
Principe P; Sidoti C; Coulomb H; Broquet C; Braquet P
Cancer Detect Prev; 1994; 18(5):393-400. PubMed ID: 7812986
[TBL] [Abstract][Full Text] [Related]
4. Cyclic oxygen analogues of alkyl-lysophospholipids. Synthesis and neoplastic cell growth inhibitory properties.
Houlihan WJ; Lee ML; Munder PG; Winslow CM; Cheon SH; D'Aries FJ; DeLillo AK; Jaeggi CS; Mason RB; Parrino VA
J Lipid Mediat; 1990; 2(5):295-307. PubMed ID: 2133273
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of 7 beta-hydroxycholesterol towards murine lymphomas, lymphoblasts and lymphocytes: selective cytotoxicity and blastogenesis inhibition.
Hietter H; Bischoff P; Beck JP; Ourisson G; Luu B
Cancer Biochem Biophys; 1986 Dec; 9(1):75-83. PubMed ID: 3815322
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of a metastatic Eb-like tumor variant highly responsive to interleukin (IL)-2 and to combination cytokine therapy with IL-2/IL-1 beta and IL-1 beta/interferon-alpha/beta.
Gabriele L; Proietti E; Greco G; Venditti M; Gresser I; Schirrmacher V; Von Hoegen P; Testa U; Modesti A; Cianfriglia M
Invasion Metastasis; 1993; 13(3):147-62. PubMed ID: 8112975
[TBL] [Abstract][Full Text] [Related]
7. Modification of cell surface carbohydrates and invasive behavior by an alkyl lysophospholipid.
Bolscher JG; Schallier DC; van Rooy H; Storme GA; Smets LA
Cancer Res; 1988 Feb; 48(4):977-82. PubMed ID: 3338089
[TBL] [Abstract][Full Text] [Related]
8. Modulation of major histocompatibility complex antigens and inhibition of proliferative activity of YAC lymphoma cells by a natural killer lysis resistance-inducing factor (NK-LRIF).
Saxena RK; Chrest FJ; Adler WH
Nat Immun Cell Growth Regul; 1989; 8(4):197-208. PubMed ID: 2571927
[TBL] [Abstract][Full Text] [Related]
9. BM 41.440: a new antineoplastic, antimetastatic, and immune-stimulating drug.
Herrmann DB; Bicker U; Pahlke W
Cancer Detect Prev Suppl; 1987; 1():361-71. PubMed ID: 3480059
[TBL] [Abstract][Full Text] [Related]
10. Multiple effects of antitumor alkyl-lysophospholipid analogs on the cytosolic free Ca2+ concentration in a normal and a breast cancer cell line.
Bergmann J; Junghahn I; Brachwitz H; Langen P
Anticancer Res; 1994; 14(4A):1549-56. PubMed ID: 7979184
[TBL] [Abstract][Full Text] [Related]
11. Novel anti-inflammatory action of edelfosine lacking toxicity with protective effect in experimental colitis.
Mollinedo F; Gajate C; Morales AI; del Canto-Jañez E; Justies N; Collía F; Rivas JV; Modolell M; Iglesias A
J Pharmacol Exp Ther; 2009 May; 329(2):439-49. PubMed ID: 19244550
[TBL] [Abstract][Full Text] [Related]
12. A novel nontoxic alkyl-phospholipid with selective antitumor activity, plasmanyl-(N-acyl)-ethanolamine (PNAE), isolated from degenerating chick embryonal tissues and from an anticancer biopreparation cACPL.
Kára J; Borovicka M; Liebl V; Smolíková J; Ubik K
Neoplasma; 1986; 33(2):187-205. PubMed ID: 3713923
[TBL] [Abstract][Full Text] [Related]
13. Cellular replication kinetics and persistence of sister chromatid exchange-inducing lesions in normal and lymphoma AKR cells following exposure to 1,3-bis(2-chloroethyl)-1-nitrosourea.
Biegel JA; Conner MK; Boggs SS
Cancer Res; 1982 Jul; 42(7):2816-20. PubMed ID: 7083172
[TBL] [Abstract][Full Text] [Related]
14. Nuclear morphology and morphometry of B-lymphocyte transformation. Implications for follicular center cell lymphomas.
Dardick I; Sinnott NM; Hall R; Bajenko-Carr TA; Setterfield G
Am J Pathol; 1983 Apr; 111(1):35-49. PubMed ID: 6340518
[TBL] [Abstract][Full Text] [Related]
15. Induction of differentiation of cultured human and mouse myeloid leukemia cells by alkyl-lysophospholipids.
Honma Y; Kasukabe T; Hozumi M; Tsushima S; Nomura H
Cancer Res; 1981 Aug; 41(8):3211-6. PubMed ID: 6941852
[TBL] [Abstract][Full Text] [Related]
16. Antitumor alkyl ether lipid edelfosine: tissue distribution and pharmacokinetic behavior in healthy and tumor-bearing immunosuppressed mice.
Estella-Hermoso de Mendoza A; Campanero MA; de la Iglesia-Vicente J; Gajate C; Mollinedo F; Blanco-Prieto MJ
Clin Cancer Res; 2009 Feb; 15(3):858-64. PubMed ID: 19188156
[TBL] [Abstract][Full Text] [Related]
17. Intracellular doxorubicin kinetics in lymphoma cells and lymphocytes infiltrating the tumor area in vivo: a flow cytometric study.
Zaleskis G; Ho RL; Diegelman P; Maccubbin D; Ujházy P; Mihich E; Ehrke MJ
Oncol Res; 1994; 6(4-5):183-94. PubMed ID: 7841541
[TBL] [Abstract][Full Text] [Related]
18. Structure-function relationships of alkyl-lysophospholipid analogs in selective antitumor activity.
Vogler WR; Olson AC; Hajdu J; Shoji M; Raynor R; Kuo JF
Lipids; 1993 Jun; 28(6):511-6. PubMed ID: 8355577
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity of leukemia cell lines to cytotoxic alkyl-lysophospholipids in relation to O-alkyl cleavage enzyme activities.
Unger C; Eibl H; Kim DJ; Fleer EA; Kötting J; Bartsch HH; Nagel GA; Pfizenmaier K
J Natl Cancer Inst; 1987 Feb; 78(2):219-22. PubMed ID: 3468284
[TBL] [Abstract][Full Text] [Related]
20. A short synthetic peptide fragment of human interleukin-1 beta increases both human and murine natural killer activity.
Peppoloni S; Bossù P; Boraschi D; Tagliabue A
Nat Immun Cell Growth Regul; 1989; 8(1):10-9. PubMed ID: 2785640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
